| Miriam Shustik, MD | |
|
2101 Emrick Blvd, Suite 202, Bethlehem, PA 18020-8040 | |
| (610) 868-1836 | |
| Not Available |
| Full Name | Miriam Shustik |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 2101 Emrick Blvd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427062736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD062421L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeastern Home Health Services | Bristol, PA | Home health agency |
| 1st Care Home Health Services Of Pennsylvania | Allentown, PA | Home health agency |
| Helping Hand Hospice, Inc | Philadelphia, PA | Hospice |
| Compassionate Care Hospice | Bensalem, PA | Hospice |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Entity Name | Miriam Shustik, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649546946 PECOS PAC ID: 9739344698 Enrollment ID: O20120628000051 |
News Archive
New PSUMMIT 2 data first presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, further demonstrate the efficacy of ustekinumab in Psoriatic Arthritis (PsA).
The international research team led by the University of Leeds found that the TSPAN12 gene is faulty in patients with a disease known as FEVR (Familial Exudative Vitreoretinopathy), which affects the development of the eye.
The next generation of drug therapies and enhanced treatment approaches for various forms of lymphoma are evolving as researchers continue to better understand how these cancers progress. Research will be presented today at the 52nd Annual Meeting of the American Society of Hematology introducing promising new options for the standard treatment of advanced asymptomatic follicular lymphoma, mantle cell lymphoma, and early, unfavorable (referring to patients with clinical stage I or II disease and one or more risk factors) Hodgkin disease.
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miriam Shustik, MD 2101 Emrick Blvd, Suite 202, Bethlehem, PA 18020-8040 Ph: (610) 868-1836 | Miriam Shustik, MD 2101 Emrick Blvd, Suite 202, Bethlehem, PA 18020-8040 Ph: (610) 868-1836 |
News Archive
New PSUMMIT 2 data first presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, further demonstrate the efficacy of ustekinumab in Psoriatic Arthritis (PsA).
The international research team led by the University of Leeds found that the TSPAN12 gene is faulty in patients with a disease known as FEVR (Familial Exudative Vitreoretinopathy), which affects the development of the eye.
The next generation of drug therapies and enhanced treatment approaches for various forms of lymphoma are evolving as researchers continue to better understand how these cancers progress. Research will be presented today at the 52nd Annual Meeting of the American Society of Hematology introducing promising new options for the standard treatment of advanced asymptomatic follicular lymphoma, mantle cell lymphoma, and early, unfavorable (referring to patients with clinical stage I or II disease and one or more risk factors) Hodgkin disease.
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
› Verified 1 days ago
Bram Sakdiponephong, MS, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 833-822-5230 | |
Shailee Pravinchandra Patel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 833-822-5230 | |
Hazem Fahmy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6643 Fax: 484-526-4658 | |
Faton Bilali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-861-8080 | |
Maria Ghetu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 610-954-3555 Fax: 610-954-3560 | |
Jose G Guzman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6048 Fax: 484-526-6500 | |
Dr. Michael Brooks Pipestone, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, St Luke's Enrollment Center, Bethlehem, PA 18015 Phone: 484-526-3285 Fax: 484-526-6500 |